GlaxoSmithKline plc (GSK) Receives Average Rating of “Hold” from Brokerages
Shares of GlaxoSmithKline plc (LON:GSK) have been assigned a consensus rating of “Hold” from the twenty-six research firms that are covering the firm. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and eight have issued a buy rating on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is GBX 1,668.38 ($20.65).
A number of analysts have issued reports on the stock. Credit Suisse Group AG reiterated a “neutral” rating and set a GBX 1,800 ($22.28) price target on shares of GlaxoSmithKline plc in a research note on Thursday, July 14th. S&P Global Inc. set a GBX 1,650 ($20.42) price target on shares of GlaxoSmithKline plc and gave the stock a “neutral” rating in a research note on Wednesday, July 27th. Beaufort Securities reiterated a “buy” rating on shares of GlaxoSmithKline plc in a research note on Tuesday, June 21st. BNP Paribas reiterated a “neutral” rating on shares of GlaxoSmithKline plc in a research note on Friday, July 29th. Finally, Citigroup Inc. set a GBX 1,800 ($22.28) price target on shares of GlaxoSmithKline plc and gave the stock a “buy” rating in a research note on Thursday, September 29th.
In other news, insider Witty,Sir Andrew P sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of GBX 1,693 ($20.95), for a total transaction of £169,300 ($209,529.70). Also, insider Slaoui,Moncef purchased 28 shares of the business’s stock in a transaction dated Friday, August 12th. The shares were bought at an average price of GBX 2,208 ($27.33) per share, with a total value of £618.24 ($765.15).
GlaxoSmithKline plc (LON:GSK) traded down 0.20% during trading on Tuesday, reaching GBX 1719.00. 7,510,673 shares of the company’s stock were exchanged. The stock has a 50-day moving average of GBX 1,645.83 and a 200-day moving average of GBX 1,556.82. The stock’s market capitalization is GBX 83.56 billion. GlaxoSmithKline plc has a 52 week low of GBX 1,277.25 and a 52 week high of GBX 1,745.56.
The business also recently declared a dividend, which will be paid on Thursday, October 13th. Stockholders of record on Thursday, August 11th will be paid a dividend of GBX 19 ($0.24) per share. This represents a dividend yield of 1.12%. The ex-dividend date is Thursday, August 11th.
About GlaxoSmithKline plc
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Stock Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related stocks with our FREE daily email newsletter.